Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-873-1 | CAS number: 544-60-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
skin:
The structural analogue (9-octadecenoic acid) was not irritating to skin.
eye:
The structural analogue (9-octadecenoic acid) was not irritating to the eye.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vivo
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- For justification of read-across see section 13.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 404 (Acute Dermal Irritation / Corrosion)
- Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- 24/48 h
- Score:
- 0.04
- Max. score:
- 4
- Reversibility:
- fully reversible within: 48h
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- 24/48 h
- Score:
- 0
- Max. score:
- 4
- Irritation parameter:
- primary dermal irritation index (PDII)
- Basis:
- mean
- Time point:
- 24/48 h
- Score:
- 0.04
- Max. score:
- 4
- Reversibility:
- fully reversible within: 48h
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- For justification of read-across see section 13.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Time point:
- 24 h
- Score:
- >= 0 - <= 2
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7d
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- 24 h
- Score:
- >= 0.42 - <= 2.1
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7d
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- 24 h
- Score:
- >= 0 - <= 1.62
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7d
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
No adequate animal data are available and no epidemiological studies investigating the skin or eye irritation potential of the test substance were identified. However, data from a structural analogue (read across substance) are available.
Skin irritation
In a skin irritation study the read across substance 9-octadecenoic acid (CAS: 112-80-1) was applied to the skin of 6 rabbits. Therefore, four test sites, approximately 10 cm apart, were prepared on the back of each animal. The hair was clipped, two of the test sites were abraded by making four epidermal incisions. Gauze patches (1.5 x 1.5 inch) were secured to the test areas by adhesive tape. 0.5 mL of the read across substance were introduced beneath the patch. The rabbits’ trunks were then wrapped in plastic trunk bands. Following the initial reading after an exposure time of 4 h, the test sites were washed. Readings were again made at 24 h and 48 h after application. The primary irritation index is calculated by adding the values for erythema or eschar formation, and edema at 4, 24 and 48 hours on intact and abraded skin (12 values) and dividing by six to obtain an individual score on each rabbit. As a result, the primary irritation index was 0.4. The mean erythema score (time 4 h /24 h /48 h) was 0.4 and the mean edema score was 0. No edema were found at any time, and erythema were reversible within 48 hours.
Eye irritation
A publication is available in which an experiment conducted on several substances that were known to cause borderline results or no irritation to eyes is described. The purpose of this experiment was to compare results of different laboratories carrying out eye irritation tests according to the Draize procedure on the same substances. Among these substances was the read across substance 9-octadecenoic acid potassium salt (CAS 143-18-0). Each substance was applied to 6 albino rabbits. The animals were observed at 24, 48 and 72 hours after application and on day 7. As a result, after 24 hours 5 out of 12 collaborating laboratories found signs of irritancy in the rabbits’ eyes caused by the analogue substance and 5 laboratories assessed borderline findings. Two collaborators did not find signs indicating eye irritation. After 48 hours signs indicating irritation were evaluated by one out of 12 collaborators and 2 collaborators had borderline findings. 9 collaborators evaluated the substance as non-irritating-. After 72 hours, the total number of animals showing any signs of eye irritation had decreased and still 9 collaborators evaluated the substance as non-irritant, 3 as borderline substance. On day 7 all tested animals were assessed symptom free. After 24 hours the mean scores for each six rabbits were between 0 and 2.0 (range 0) for corneal opacity, 0 - 0.65 for iritis, 0.42 - 2.1 for conjunctival redness and 0 - 1.62 for chemosis. Mean scores after 48 and 72 hours are not given in the publication. However, considering that the number of animals exhibiting signs of irritancy decreased during the observation period and even if assumed that the scores given for each finding stayed the same after 48 and 72 hours, the mean scores are will not increase for any symptom. The critical score for classification is therefore the mean cornea score of 2.0.
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for skin or eye irritation under Directive 67/548/EEC, as amended for the 31st time in Directive 2009/2/EG.
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. As a result the substance is not considered to be classified for skin or eye irritation under Regulation (EC) No 1272/2008, as amended for the sixth time in Regulation EC 605/2014.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.